Table 4.
Mean scores of the single items of the BCM-20 of short-term survivors
| Symptom | Baseline Mean (SD) | 4-Month Follow-up Mean (SD) | p Valuea Mean |
|---|---|---|---|
| Future uncertainty | 51.4 (26.9) | 51.1 (28.0) | NS |
| Visual disorder | 20.8 (20.2) | 15.6 (12.5) | NS |
| Motor dysfunction | 19.4 (20.1) | 33.0 (34.8) | NS |
| Communication deficit | 20.1 (30.4) | 25.2 (32.1) | NS |
| Headache | 35.4 (37.5) | 24.4 (29.5) | NS |
| Seizures | 12.5 (26.9) | 26.7 (31.4) | NS |
| Drowsiness | 22.9 (23.5) | 26.2 (23.3) | NS |
| Leg weakness | 12.5 (20.6) | 35.6 (32.0) | 0.026 |
Abbreviations: BCM-20, 20-item Brain Cancer Module; NS, not significant.
a
Nonparametric (Wilcoxon).